Mark B. Skeen

1.5k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Mark B. Skeen is a scholar working on Pathology and Forensic Medicine, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark B. Skeen has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark B. Skeen's work include Multiple Sclerosis Research Studies (9 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Mark B. Skeen is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Autoimmune Neurological Disorders and Treatments (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Mark B. Skeen collaborates with scholars based in United States, Australia and Denmark. Mark B. Skeen's co-authors include Jeffrey Raizer, Xiaoyu Peng, Akio Kimura, Ethan G. Hughes, Wolfgang Grisold, Daniel Friedman, Radu Constantinescu, Takahiro Iizuka, Meizan Lai and Eric Lancaster and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The Lancet Neurology.

In The Last Decade

Mark B. Skeen

20 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen

2009 652 citations Eric Lancaster, Meizan Lai et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark B. Skeen United States	8	705	240	207	198	193	21	1.1k
Stacey Clardy United States	18	819 1.2×	137 0.6×	173 0.8×	120 0.6×	195 1.0×	75	1.2k
Rinze F. Neuteboom Netherlands	25	928 1.3×	175 0.7×	280 1.4×	203 1.0×	725 3.8×	71	1.7k
Amy May Lin Quek United States	9	865 1.2×	147 0.6×	217 1.0×	149 0.8×	317 1.6×	14	1.0k
Elizabeth D. Tate United States	22	869 1.2×	82 0.3×	102 0.5×	262 1.3×	129 0.7×	44	1.1k
Jessica A. Panzer United States	18	390 0.6×	210 0.9×	324 1.6×	152 0.8×	53 0.3×	28	903
Esther Tantsis Australia	13	889 1.3×	119 0.5×	122 0.6×	58 0.3×	790 4.1×	20	1.3k
Canan Ulusoy Türkiye	18	372 0.5×	107 0.4×	126 0.6×	66 0.3×	103 0.5×	53	670
A. Vincent United Kingdom	10	786 1.1×	208 0.9×	229 1.1×	156 0.8×	37 0.2×	17	988
Giovanni Castelnovo France	19	515 0.7×	229 1.0×	375 1.8×	39 0.2×	250 1.3×	74	1.1k
Sabrina Matà Italy	16	1.2k 1.7×	469 2.0×	258 1.2×	205 1.0×	215 1.1×	47	1.5k

Countries citing papers authored by Mark B. Skeen

Since Specialization

Citations

This map shows the geographic impact of Mark B. Skeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Skeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Skeen more than expected).

Fields of papers citing papers by Mark B. Skeen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Skeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Skeen. The network helps show where Mark B. Skeen may publish in the future.

Co-authorship network of co-authors of Mark B. Skeen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Skeen. A scholar is included among the top collaborators of Mark B. Skeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Skeen. Mark B. Skeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolthusen, Rick P.F., et al.. (2023). A Multimedia Description of Catatonia Secondary to Anti–NMDA-Receptor Encephalitis. The Primary Care Companion For CNS Disorders. 25(5). 2 indexed citations

Kimbrough, Dorlan, et al.. (2022). Neuromyelitis optica: Clinical course and potential prognostic indicators. Multiple Sclerosis and Related Disorders. 69. 104414–104414. 5 indexed citations

Lutz, Michael W., et al.. (2022). Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center. Journal of Neuroimmunology. 373. 577987–577987. 6 indexed citations

Yang, Jui‐Chen, Shelby D. Reed, Steven Hass, Mark B. Skeen, & F. Reed Johnson. (2021). Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff Preferences. Medical Decision Making. 41(2). 222–232. 5 indexed citations

Alschuler, Kevin N., Gloria von Geldern, Kathleen Costello, et al.. (2020). Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS. Multiple Sclerosis and Related Disorders. 46. 102600–102600. 2 indexed citations

Skeen, Mark B. & Luca Pani. (2020). Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues. Journal of Clinical Neurophysiology. 38(3). 181–185. 1 indexed citations

Skeen, Mark B.. (2020). Changing Paradigms and Unmet Needs in Multiple Sclerosis: The Role of Clinical Neurophysiology. Journal of Clinical Neurophysiology. 38(3). 162–165. 3 indexed citations

Skeen, Mark B., et al.. (2019). The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series. Journal of Neuroimmunology. 337. 577078–577078. 11 indexed citations

Dunn‐Pirio, Anastasie, et al.. (2018). Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma. SHILAP Revista de lepidopterología. 2018. 1–4. 43 indexed citations

10.

Skeen, Mark B., et al.. (2018). Recurrent disseminated encephalomyelitis: A case report and literature review. Multiple Sclerosis and Related Disorders. 26. 86–89. 4 indexed citations

11.

Tran, Linh, et al.. (2018). Progressive multifocal leukoencephalitis in a patient with sarcoidosis on hydroxychloroquine with negative cerebrospinal fluid testing for the John Cunningham virus. Neuroimmunology and Neuroinflammation. 5(1). 3–3.

12.

Cadavid, Diego, Laura J. Balcer, Steven Galetta, et al.. (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. The Lancet Neurology. 16(3). 189–199. 197 indexed citations

13.

Plummer, Prudence, et al.. (2016). Combining Dalfampridine with Physical Therapy May Improve Treatment Effects in Dalfampridine Non-responders with Multiple Sclerosis: A Case Study. Archives of Physical Medicine and Rehabilitation. 97(10). e62–e62. 1 indexed citations

14.

Kolls, Brad J., DaiWai M. Olson, William B. Gallentine, et al.. (2012). Electroencephalography Leads Placed by Nontechnologists Using a Template System Produce Signals Equal in Quality to Technologist-Applied, Collodion Disk Leads. Journal of Clinical Neurophysiology. 29(1). 42–49. 14 indexed citations

15.

Lancaster, Eric, Meizan Lai, Xiaoyu Peng, et al.. (2009). Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. The Lancet Neurology. 9(1). 67–76. 652 indexed citations breakdown →

16.

Ferrara, Joseph M., Mark B. Skeen, Nancy Edwards, Linda Gray, & E. Wayne Massey. (2007). Subacute Combined Degeneration Due to Copper Deficiency. Journal of Neuroimaging. 17(4). 375–377. 7 indexed citations

17.

McCrory, Douglas C, et al.. (2004). Criteria to determine disability related to multiple sclerosis.. PubMed. 1–8. 3 indexed citations

18.

Skeen, Mark B.. (2002). Neurologic Manifestations of Gastrointestinal Disease. Neurologic Clinics. 20(1). 195–225. 19 indexed citations

19.

Vinik, Aaron I., Gary L. Pittenger, Taesun Park, Tomris Erbaş, & Mark B. Skeen. (2001). Neurotrophic factors in diabetic neuropathy. Current Opinion in Endocrinology & Diabetes. 8(4). 205–212. 2 indexed citations

20.

Nohria, Virinder, Namsoo Lee, R D Tien, et al.. (1994). Magnetic Resonance Imaging Evidence of Hippocampal Sclerosis in Progression: A Case Report. Epilepsia. 35(6). 1332–1336. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact